By activating the MAPK and NF-κB pathways, which are downstream of neurotensin (NTS) signaling, IL-8 has been demonstrated to promote EMT and tumor invasion in hepatocellular carcinoma (HCC). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.